Establishing the CQAs of a mAb product by evaluating impact and uncertainty during risk assessment.
Andrew J. Reason
Advertisement
Articles by Andrew J. Reason
The author describes techniques that can be used to provide the analytical data required by ICH Q6B for characterization of monoclonal antibodies.
Advertisement
Latest Updated Articles
Structural Characterization of Monoclonal AntibodiesPublished: August 2nd 2011 | Updated:
Defining Critical Quality Attributes for Monoclonal Antibody Therapeutic ProductsPublished: July 1st 2014 | Updated:
Advertisement
Advertisement
